4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Helix BioPharma Corp. (HBP) operates in the Biotechnology industry and is headquartered in Vancouver, Canada. Its market capitalization is roughly C$75 million.
Helix BioPharma Corp. a clinical-stage biopharmaceutical company developing therapies in the field of immune-oncology in Canada.
Interactive charts & full statements →
| Income statement | 2025-07-31 | 2024-07-31 | 2023-07-31 | 2022-07-31 |
|---|---|---|---|---|
| Total Revenue | — | C$0M | C$0M | C$0M |
| Operating Income (EBIT) | — | (C$9M) | (C$6M) | (C$6M) |
| Net Income | — | (C$9M) | (C$6M) | (C$7M) |
CAD; C$M / C$B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-04-30 | 2026-01-31 | 2025-10-31 | 2025-07-31 | 2025-04-30 | 2025-01-31 |
|---|---|---|---|---|---|---|
| Total Revenue | C$0M | C$0M | C$0M | — | C$0M | C$0M |
| Operating Income (EBIT) | (C$1M) | (C$1M) | (C$1M) | — | (C$2M) | (C$1M) |
| Net Income | (C$1M) | (C$1M) | (C$1M) | — | (C$2M) | (C$1M) |
CAD; C$M / C$B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2024-07-31 | 2023-07-31 | 2022-07-31 |
|---|---|---|---|
| Total Assets | C$2M | C$1M | C$4M |
| Total Liabilities | C$2M | C$2M | C$3M |
CAD; C$M / C$B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive HBP viewer.
About TickerBase · Data methodology & sources · Privacy · Terms